Biomarker sensor developer Lucerno Dynamics raised $6.3 million in a Series A round of equity financing, according to an SEC filing posted today.
Money in the round includes $5.2 million in new funds and $1.1 million in convertible debt, raised earlier in 2016.
Lucerno Dynamics is developing a device to detect and monitor biomarkers used in PET or SPECT scans, according to the company’s website.
The sensor can operate with any PET or SPECT radiotracers in tissue, with proposed uses in verifying the quality of PET injections, measuring arterial input function, assessing inflammation, monitoring superficial tumors and other uses.
“We are very pleased with the response to our first fundraising campaign. This completes our initial quest and it will enable us to fund the commercial launch of the first application of Lucerno sensor technology, and sets us up to explore additional applications of the technology,” CEO Ron Lattanze told the Triangle Business Journal.
Money in the round came from 23 anonymous sources, according to an SEC filing., and the company has not yet said how it plans to use funds raised in the round.
